729 shareholders attended the 25th Annual General Meeting of SFS Group AG, which took place yesterday. They represented 81.9% of the votes. All proposals by the Board of Directors were approved by a large majority.
On 25 April 2018, the Chairman of the Board, Heinrich Spoerry, welcomed 729 shareholders to the 25th Annual General Meeting (AGM) of SFS Group AG at the Aegeten sports centre in Widnau (Switzerland). They represented 30.711.980 shares, which corresponds to 81.9% of the share capital.
In his short speech, Heinrich Spoerry commented on the successful 2017 financial year. SFS Group generated dynamic sales growth and improved its position in the medical device industry and in the Americas thanks to the integration of Tegra Medical. Jens Breu, CEO of the SFS Group, informed about important projects, which will lay the basis for SFS' further growth. Rolf Frei, CFO of the SFS Group, gave his comments on selected financial aspects of the 2017 financial year.
During the statutory part of the meeting, shareholders approved the management report, the financial statements and the consolidated financial statements. All members of the Board of Directors were re-elected and the compensation to members of the Board of Directors and the Group Executive Board was also approved. The shareholders released both boards, the Board of Directors and the Group Executive Board, from liability for their activities.
Likewise, the law firm bürki bolt németh in Heerbrugg was re-elected as independent proxy and PricewaterhouseCoopers AG in St. Gallen was re-elected as auditor.
The shareholders also approved the payout of CHF 1.90 per share from capital contributions reserves. This represents an increase in payout of 8.6% compared to the previous year (CHF 1.75).